Defer - Generic Drug Details
✉ Email this page to a colleague
US Patents and Regulatory Information for defer
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | DEFEROXAMINE MESYLATE | deferoxamine mesylate | INJECTABLE;INJECTION | 078718-001 | Sep 15, 2009 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chiesi | FERRIPROX | deferiprone | TABLET;ORAL | 212269-001 | May 19, 2020 | RX | Yes | Yes | 11,458,103 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Alembic | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 210060-002 | Nov 20, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sun Pharm | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 209782-001 | Nov 20, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Alkem Labs Ltd | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 210519-002 | Nov 20, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

